On behalf of the chairman of the board of directors of the Saudi Food and Drug Authority (SFDA), Saudi Arabia’s Minister of Economy and Planning Mr. Faisal bin Fadel Al-Ibrahim has signed a memorandum of understanding (MoU) with the National Authority of Medicines and Health Products in Portugal.
The MoU was signed on the sidelines of the meeting of the sixth session of the Saudi-Portuguese Joint Committee held in the Portuguese capital.
The MoU aims to enhance joint cooperation and exchange information and expertise between the two regulatory bodies in the field of regulating medicines, medical devices and supplies, cosmetic products, and other related fields such as laboratories and inspection.
The two parties will exchange experiences, information, technical visits, and establish on-the-job training programs in activities related to laboratory tests for biological preparations, evaluation of similar preparations (manufacturing and chemical control), and evaluation of bioequivalence studies.
According to the statement, “Further, they will conduct clinical trials and good clinical practice (GCP), and tests of the safety and effectiveness of medical devices and supplies for the purposes of licensing, marketing, and post-marketing control.”
Saudi Food and Drug Authority aims to be a leading international science-based regulator to protect and promote public health. SFDA’s main goal is to protect the community through regulations and effective controls to ensure the safety of food, drugs, medical devices, cosmetics, pesticides, and feed.
